相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dendritic cell targeting with Fc-enhanced CD40 antibody agonists induces durable antitumor immunity in humanized mouse models of bladder cancer
Christopher S. Garris et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Siglecs-7/9 function as inhibitory immune checkpoints in vivo and can be targeted to enhance therapeutic antitumor immunity
Itziar Ibarlucea-Benitez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Fc-optimized antibodies elicit CD8 immunity to viral respiratory infection
Stylianos Bournazos et al.
NATURE (2020)
Intratumoral injection reduces toxicity and antibody-mediated neutralization of immunocytokine in a mouse melanoma model
Claire C. Baniel et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Functional humanization of immunoglobulin heavy constant gamma 1 Fc domain humanFCGRTtransgenic mice
Benjamin E. Low et al.
MABS (2020)
Antibodies targeting sialyl Lewis A mediate tumor clearance through distinct effector pathways
Polina Weitzenfeld et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
An engineered human Fc domain that behaves like a pH-toggle switch for ultra-long circulation persistence
Chang-Han Lee et al.
NATURE COMMUNICATIONS (2019)
Increasing the breadth and potency of response to the seasonal influenza virus vaccine by immune complex immunization
Jad Maamary et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Evaluating the Murine Anti-Human Antibody Response and Assessment of General Activity and Cognition after Treatment with Human Intravenous Immunoglobulins in Healthy Adult C57/B6J Mice
I. Fülber et al.
European Journal of Inflammation (2017)
Massive immune response against IVIg interferes with response against other antigens in mice: A new mode of action?
Laetitia Sorde et al.
PLOS ONE (2017)
HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption
Johannes F. Scheid et al.
NATURE (2016)
Antagonistic Human FcγRIIB (CD32B) Antibodies Have Anti-Tumor Activity and Overcome Resistance to Antibody Therapy In Vivo
Ali Roghanian et al.
CANCER CELL (2015)
Anti-HA Glycoforms Drive B Cell Affinity Selection and Determine Influenza Vaccine Efficacy
Taia T. Wang et al.
CELL (2015)
Pathways Responsible for Human Autoantibody and Therapeutic Intravenous IgG Activity in Humanized Mice
Inessa Schwab et al.
CELL REPORTS (2015)
T cell-independent B cell activation induces immunosuppressive sialylated IgG antibodies
Constanze Hess et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
General mechanism for modulating immunoglobulin effector function
Peter Sondermann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Mouse model recapitulating human Fcγ receptor structural and functional diversity
Patrick Smith et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Intravenous gammaglobulin suppresses inflammation through a novel TH2 pathway
Robert M. Anthony et al.
NATURE (2011)
Alport Alloantibodies but Not Goodpasture Autoantibodies Induce Murine Glomerulonephritis: Protection by Quinary Crosslinks Locking Cryptic α3(IV) Collagen Autoepitopes In Vivo
Wentian Luo et al.
JOURNAL OF IMMUNOLOGY (2010)
Identification of a receptor required for the anti-inflammatory activity of IVIG
Robert M. Anthony et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity
Falk Nimmerjahn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Divergent immunoglobulin G subclass activity through selective Fc receptor binding
F Nimmerjahn et al.
SCIENCE (2005)
分享论文
